Junyu Long

3.8k citations

82 papers · 2.0k indexed · h-index 27

Impact in

Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in ⓘ

Oncology 39
- Cancer Immunotherapy and Biomarkers 16
- Pancreatic and Hepatic Oncology Research 13
Surgery 36
- Cholangiocarcinoma and Gallbladder Cancer Studies 32

Co-authors: Haitao Zhao (61 shared papers)Jianzhen Lin (33 shared papers)Yi Bai (31 shared papers)Xiaobo Yang (34 shared papers)Dongxu Wang (23 shared papers)Xinting Sang (45 shared papers)Xu Yang (9 shared papers)Anqiang Wang (9 shared papers)
Journals: World Journal of Gastroenterology (9 papers)Annals of Translational Medicine (5 papers)International Immunopharmacology (4 papers)Frontiers in Oncology (4 papers)Cancer Immunology Immunotherapy (3 papers)
Partner nations: China United States Germany

In The Last Decade

Junyu Long

81 papers receiving 2.0k citations

Peers

Countries citing papers authored by Junyu Long

Since Specialization

Citations

This map shows the geographic impact of Junyu Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyu Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyu Long more than expected).

Fields of papers citing papers by Junyu Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyu Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyu Long. The network helps show where Junyu Long may publish in the future.

Co-authors

The 25 scholars most cited alongside Junyu Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Junyu Long Line = papers co-authored together Junyu Long links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma EBioMedicine ·Junyu Long, Anqiang Wang, Yi Bai, Jianzhen Lin, Xu Yang, Dongxu Wang, Xiaobo Yang, Yan Jiang, Haitao Zhao	2019	252
2	A four‐gene‐based prognostic model predicts overall survival in patients with hepatocellular carcinoma Journal of Cellular and Molecular Medicine ·Junyu Long, Lei Zhang, Xueshuai Wan, Jianzhen Lin, Yi Bai, Weiyu Xu, Jianping Xiong, Haitao Zhao	2018	109
3	DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma Theranostics ·Junyu Long, Peipei Chen, Jianzhen Lin, Yi Bai, Xu Yang, Jin‐Song Bian, Yu Lin, Dongxu Wang, Xiaobo Yang, Yongchang Zheng, Xinting Sang, Haitao Zhao	2019	99
4	Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression Journal of Cellular Physiology ·Yi Bai, Junyu Long, Zhisong Liu, Jianzhen Lin, Hanchan Huang, Dongxu Wang, Yang Xu, Fei Miao, Yilei Mao, Xinting Sang, Haitao Zhao	2019	92
5	Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma Cancer Cell International ·Junyu Long, Yi Bai, Xiaobo Yang, Jianzhen Lin, Xu Yang, Dongxu Wang, Li He, Yongchang Zheng, Haitao Zhao	2019	84
6	PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy Journal of Hematology & Oncology ·Junyu Long, Jianzhen Lin, Anqiang Wang, Liangcai Wu, Yongchang Zheng, Xiaobo Yang, Xueshuai Wan, Haifeng Xu, Shuguang Chen, Haitao Zhao	2017	84
7	Alterations in DNA Damage Repair Genes in Primary Liver Cancer Clinical Cancer Research ·Jianzhen Lin, Junping Shi, Honglin Guo, Xu Yang, Yan Jiang, Junyu Long, Yi Bai, Dongxu Wang, Xiaobo Yang, Xueshuai Wan, Lei Zhang, Jie Pan, Ke Hu, Mei Guan, Li Huo, Xinting Sang, Kai Wang, Haitao Zhao	2019	80
8	Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies Journal of Hematology & Oncology ·Dongxu Wang, Jianzhen Lin, Xu Yang, Junyu Long, Yi Bai, Xiaobo Yang, Yilei Mao, Xinting Sang, Samuel Seery, Haitao Zhao	2019	69
9	Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients World Journal of Gastroenterology ·Weiyu Xu, Haohai Zhang, Jianping Xiong, Xiaobo Yang, Yi Bai, Jianzhen Lin, Junyu Long, Yongchang Zheng, Haitao Zhao, Xinting Sang	2018	57
10	T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy. American Journal of Cancer Research ·Jin‐Song Bian, Jianzhen Lin, Junyu Long, Yang Xu, Xiaobo Yang, Xin Lu, Xinting Sang, Haitao Zhao	2020	49
11	Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis Briefings in Bioinformatics ·Junyu Long, Shan Huang, Yi Bai, Jinzhu Mao, Anqiang Wang, Yu Lin, Xu Yang, Dongxu Wang, Jianzhen Lin, Jin‐Song Bian, Xiaobo Yang, Xinting Sang, Xi Wang, Haitao Zhao	2020	47
12	Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia Prostate Cancer and Prostatic Diseases ·J M Devaney, S Wang, S Funda, Junyu Long, Delaram J. Taghipour, Rana Tbaishat, P Furbert-Harris, Michael Ittmann, Bernard Kwabi‐Addo	2013	46
13	Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes International Journal of Biological Sciences ·Yi Bai, Chunlian Wei, Yuxin Zhong, Yamin Zhang, Junyu Long, Shan Huang, Fucun Xie, Yantao Tian, Xi Wang, Haitao Zhao	2020	43
14	Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression BMC Cancer ·Jianzhen Lin, Junyu Long, Xueshuai Wan, Jingci Chen, Yi Bai, Anqiang Wang, Xiaobo Yang, Yan Wu, Simon C. Robson, Xinting Sang, Haitao Zhao	2018	40
15	Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy BMC Medicine ·Junyu Long, Dongxu Wang, Xu Yang, Anqiang Wang, Yu Lin, Mingjun Zheng, Haohai Zhang, Xinting Sang, Hanping Wang, Ke Hu, Haitao Zhao	2021	39
16	Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy HepatoBiliary Surgery and Nutrition ·Xiaobo Yang, Haifeng Xu, Bangyou Zuo, Yang Xu, Jin‐Song Bian, Junyu Long, Dongxu Wang, Junwei Zhang, Ning Cong, Yanyu Wang, Ziyu Xun, Yunchao Wang, Xin Lü, Yilei Mao, Xinting Sang, Haitao Zhao	2021	37
17	A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape Genome Medicine ·Junyu Long, Dongxu Wang, Anqiang Wang, Peipei Chen, Yu Lin, Jin‐Song Bian, Xu Yang, Mingjun Zheng, Haohai Zhang, Yongchang Zheng, Xinting Sang, Haitao Zhao	2022	37
18	Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China World Journal of Gastroenterology ·Dongxu Wang, Yang Xu, Jianzhen Lin, Yi Bai, Junyu Long, Xiaobo Yang, Samuel Seery, Haitao Zhao	2020	34
19	Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients World Journal of Gastroenterology ·Weiyu Xu, Haohai Zhang, Xiaobo Yang, Yi Bai, Jianzhen Lin, Junyu Long, Jianping Xiong, Junwei Zhang, Xinting Sang, Haitao Zhao	2018	33
20	Dyslipidemia Might Be Associated with an Increased Risk of Osteoarthritis BioMed Research International ·Jianping Xiong, Junyu Long, Xi Chen, Ye Li, Hai Song	2020	33

About Junyu Long

Junyu Long is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 82 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (32 papers), Ferroptosis and cancer prognosis (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (13 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Gallbladder and Bile Duct Disorders (9 papers). The work is most often cited by research in Cancer Research (750 citations), Hepatology (266 citations), Oncology (781 citations), Pulmonary and Respiratory Medicine (726 citations) and Molecular Biology (798 citations). Junyu Long has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Haitao Zhao, Jianzhen Lin, Yi Bai, Xiaobo Yang, Dongxu Wang, Xinting Sang, Xu Yang, Anqiang Wang, Jianping Xiong and Weiyu Xu. Their work appears in journals such as World Journal of Gastroenterology, Annals of Translational Medicine, International Immunopharmacology, Frontiers in Oncology and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact